Yves Lévy
#10,878
Most Influential Person Now
French immunologist
Yves Lévy's AcademicInfluence.com Rankings
Yves Lévybiology Degrees
Biology
#897
World Rank
#1577
Historical Rank
Immunology
#14
World Rank
#17
Historical Rank
Download Badge
Biology
Why Is Yves Lévy Influential?
(Suggest an Edit or Addition)According to Wikipedia, Yves Lévy is a French physician researcher and professor of clinical immunology who served as CEO of the French Institute of Health and Medical Research from 2014 until 2018. Early life and education Lévy was born in Casablanca, Morocco, and arrived in France with his parents in 1973. He was naturalised one and a half years later. His passion was literature, before he turned to medicine. After studying medicine and finishing his residency he dedicated himself to HIV research in 1986.
Yves Lévy's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus (1995) (561)
- Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. (2004) (432)
- Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM (2001) (369)
- Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. (1994) (365)
- Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. (2009) (362)
- HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. (2010) (347)
- Interleukin-2 therapy in patients with HIV infection. (2009) (291)
- Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). (2009) (255)
- Neuronal apoptosis in HIV infection in adults (1995) (249)
- CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses (2017) (208)
- Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study (2012) (203)
- Autoimmune Thrombocytopenic Purpura and Common Variable Immunodeficiency: Analysis of 21 Cases and Review of the Literature (2004) (180)
- NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. (2012) (179)
- CD39/Adenosine Pathway Is Involved in AIDS Progression (2011) (159)
- Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial (1999) (158)
- Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graft. (1989) (157)
- Role of miR‐155 in the regulation of lymphocyte immune function and disease (2014) (143)
- Common variable immunodeficiency is associated with defective functions of dendritic cells. (2004) (136)
- Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults (2007) (126)
- Suppression of HIV-1 replication by microRNA effectors (2009) (120)
- Intrinsic Defect in Keratinocyte Function Leads to Inflammation in Hidradenitis Suppurativa. (2016) (119)
- Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial (2003) (117)
- Natural antibodies sustain differentiation and maturation of human dendritic cells. (2004) (115)
- Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients (2005) (115)
- Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03). (2009) (113)
- Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines. (1991) (111)
- Dendritic cell‐based therapeutic vaccine elicits polyfunctional HIV‐specific T‐cell immunity associated with control of viral load (2014) (107)
- Defect in IgV gene somatic hypermutation in common variable immuno-deficiency syndrome. (1998) (107)
- High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. (2004) (96)
- Common variable immunodeficiency: the immune system in chaos. (2005) (94)
- Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients. (2001) (93)
- In vivo imaging of inflammasome activation reveals a subcapsular macrophage burst response that mobilizes innate and adaptive immunity (2015) (92)
- Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders (2014) (92)
- In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2–treated HIV patients (2010) (92)
- Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. (2010) (91)
- Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. (2011) (91)
- Myelodysplastic syndrome and associated skin lesions: a review of the literature. (1999) (88)
- Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models. (2017) (87)
- Impaired Antibody Affinity Maturation Process Characterizes a Subset of Patients with Common Variable Immunodeficiency1 (2000) (86)
- Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals (2006) (83)
- Regulatory T Cells Negatively Affect IL-2 Production of Effector T Cells through CD39/Adenosine Pathway in HIV Infection (2013) (74)
- Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients (2014) (66)
- Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies. (2011) (64)
- Nonpathogenesis of Simian Immunodeficiency Virus Infection Is Associated with Reduced Inflammation and Recruitment of Plasmacytoid Dendritic Cells to Lymph Nodes, Not to Lack of an Interferon Type I Response, during the Acute Phase (2009) (63)
- Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial. (2020) (62)
- Subcapsular sinus macrophages promote NK cell accumulation and activation in response to lymph-borne viral particles. (2012) (61)
- Acute rhabdomyolysis in patients infected by human immunodeficiency virus (1994) (60)
- HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection (2008) (60)
- AIDS Progression Is Associated with the Emergence of IL-17–Producing Cells Early After Simian Immunodeficiency Virus Infection (2009) (60)
- Immune response to HIV (2013) (60)
- In vitro identification of human pro-B cells that give rise to macrophages, natural killer cells, and T cells. (2003) (58)
- Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults (2006) (57)
- Interruption of antiretroviral therapy initiated during primary HIV-1 infection: impact of a therapeutic vaccination strategy combined with interleukin (IL)-2 compared with IL-2 alone in the ANRS 095 Randomized Study. (2007) (57)
- Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies (2020) (56)
- Acute kidney injury in sickle patients with painful crisis or acute chest syndrome and its relation to pulmonary hypertension. (2010) (56)
- Gut microbiota associated with HIV infection is significantly enriched in bacteria tolerant to oxygen (2016) (55)
- Relationship between Regulatory T Cells and Immune Activation in Human Immunodeficiency Virus-Infected Patients Interrupting Antiretroviral Therapy (2010) (55)
- Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies. (2016) (52)
- Human CD90 Identifies Th17/Tc17 T Cell Subsets That Are Depleted in HIV-Infected Patients (2012) (52)
- Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2. ANRS 048 IL-2 Study Group. (1999) (50)
- COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study (2021) (49)
- Early Divergence in Neutrophil Apoptosis between Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infections of Nonhuman Primates12 (2008) (48)
- Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives (2020) (47)
- Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets. (2009) (47)
- TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs (2018) (46)
- Acute varicella-zoster virus ventriculitis and mengingo-myelo-radiculitis in acquired immunodeficiency syndrome (2004) (46)
- Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial (2010) (46)
- Expression of GpIb on plasma cells in a patient with monoclonal IgG and acquired von Willebrand disease (1993) (44)
- Interleukin 6 dependence of spontaneous in vitro differentiation of B cells from patients with IgM gammapathy. (1990) (43)
- Notch ligands potentiate IL‐7‐driven proliferation and survival of human thymocyte precursors (2009) (42)
- IL-7 Modulates In Vitro and In Vivo Human Memory T Regulatory Cell Functions through the CD39/ATP Axis (2013) (42)
- Targeting concatenated HIV antigens to human CD40 expands a broad repertoire of multifunctional CD4+ and CD8+ T cells (2013) (42)
- Retinoic acid modulates the in vivo and in vitro growth of IL‐6 autocrine human myeloma cell lines via induction of apoptosis (1996) (41)
- CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death (2021) (41)
- Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome (2020) (40)
- BK virus encephalitis in a patient with AIDS and lymphoma. (2001) (40)
- DNA/NYVAC Vaccine Regimen Induces HIV-Specific CD4 and CD8 T-Cell Responses in Intestinal Mucosa (2011) (39)
- Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine. (2011) (38)
- Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1 (2015) (38)
- HIV-1 protease folding and the design of drugs which do not create resistance. (2008) (38)
- A nonsense mutation in the LDL receptor gene leads to familial hypercholesterolemia in the Druze sect. (1992) (38)
- The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients (2021) (36)
- HIV "elite controllers" are characterized by a high frequency of memory CD8+ CD73+ T cells involved in the antigen-specific CD8+ T-cell response. (2014) (36)
- Therapeutic vaccines and immunological intervention in HIV infection: a paradigm change (2016) (36)
- Microbiome of HIV-infected people. (2017) (35)
- Macrophage- and Neutrophil-Derived TNF-α Instructs Skin Langerhans Cells To Prime Antiviral Immune Responses (2014) (35)
- DC Subsets Regulate Humoral Immune Responses by Supporting the Differentiation of Distinct Tfh Cells (2019) (35)
- Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system. (2017) (34)
- Short exposure to Notch ligand Delta-4 is sufficient to induce T-cell differentiation program and to increase the T cell potential of primary human CD34+ cells. (2006) (33)
- Hypothermic Total Liquid Ventilation Is Highly Protective Through Cerebral Hemodynamic Preservation and Sepsis-Like Mitigation After Asphyxial Cardiac Arrest* (2015) (33)
- Notch Increases T/NK Potential of Human Hematopoietic Progenitors and Inhibits B Cell Differentiation at a Pro‐B Stage (2009) (32)
- Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patients. (2001) (32)
- Maraviroc-containing regimen suppresses HIV replication in the cerebrospinal fluid of patients with neurological symptoms (2010) (32)
- Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients (2016) (32)
- Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1 (2012) (31)
- Brucella β 1,2 Cyclic Glucan Is an Activator of Human and Mouse Dendritic Cells (2012) (31)
- The role of autologous blood stem cells in support of high-dose therapy for multiple myeloma. (1992) (30)
- Exploiting differential expression of the IL-7 receptor on memory T cells to modulate immune responses. (2014) (30)
- Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease (2014) (30)
- Long-lasting severe immune dysfunction in Ebola virus disease survivors (2019) (30)
- Long-lasting severe immune dysfunction in Ebola virus disease survivors (2019) (30)
- Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults. (2010) (29)
- Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response (2018) (28)
- HIV infection en route to endogenization: two cases (2014) (28)
- First evidence of subclinical renal tubular injury during sickle-cell crisis (2014) (27)
- Quantifying and Predicting the Effect of Exogenous Interleukin-7 on CD4+T Cells in HIV-1 Infection (2014) (27)
- Primary vasculitis of the central nervous system in patients infected with HIV‐1 in the HAART era (2009) (26)
- Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses (2017) (26)
- Identification of Vaccine-Altered Circulating B Cell Phenotypes Using Mass Cytometry and a Two-Step Clustering Analysis (2016) (26)
- Long-term effects of intermittent interleukin-2 therapy in chronic HIV-infected patients (ANRS 048–079 Trials)* (2007) (25)
- Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119). (2009) (25)
- HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood (2019) (25)
- Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response (2020) (24)
- Hair follicle stem cell replication stress drives IFI16/STING-dependent inflammation in hidradenitis suppurativa. (2020) (24)
- Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination (2019) (24)
- Decreased HIV-Specific T-Regulatory Responses Are Associated with Effective DC-Vaccine Induced Immunity (2015) (24)
- Notch activation on effector T cells increases their sensitivity to Treg cell‐mediated suppression through upregulation of TGF‐βRII expression (2012) (24)
- A highly virulent variant of HIV-1 circulating in the Netherlands (2022) (23)
- Therapeutic HIV-1 vaccine: time for immunomodulation and combinatorial strategies (2018) (22)
- Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV (2012) (22)
- Beneficial effect of highly active antiretroviral therapy on the prognosis of AIDS-related systemic non-Hodgkin lymphomas. (2005) (22)
- Vaccine and immunotherapeutic interventions (2013) (22)
- P2X7 Receptor Inhibition Improves CD34 T-Cell Differentiation in HIV-Infected Immunological Nonresponders on c-ART (2016) (21)
- Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course (2017) (21)
- Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03A adjuvant in HIV-1-infected adults (2013) (20)
- T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials (2016) (20)
- Characterization of a human monoclonal autoantibody directed to cardiolipin/β2 glycoprotein I produced by chronic lymphocytic leukaemia B cells (1993) (20)
- Identification of IL7RA risk alleles for rapid progression during HIV-1 infection: a comprehensive study in the GRIV cohort. (2012) (20)
- Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques (2016) (20)
- Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers (2013) (19)
- Disease-Modifying Therapeutic Concepts for HIV in the Era of Highly Active Antiretroviral Therapy (2011) (19)
- Accelerated thymopoiesis and improved T‐cell responses in HLA‐A2/‐DR2 transgenic BRGS‐based human immune system mice (2019) (19)
- Acute activation of CD8+ T lymphocytes in interleukin-2-treated HIV-infected patients. ANRS-048 IL-2 Study Group. Agence Nationale de Recherches sur le SIDA. (1999) (18)
- Intensive Chemotherapy (LNHIV-91 Regimen) and G-CSF for HIV Associated Non-Hodgkin's Lymphoma (2000) (18)
- Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial (2019) (18)
- Phenotype and immunoglobulin gene configuration of blood B cells from patients with multiple myeloma. (1991) (18)
- Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs (2022) (18)
- Intradermal injection of an anti‐Langerin‐HIVGag fusion vaccine targets epidermal Langerhans cells in nonhuman primates and can be tracked in vivo (2016) (17)
- Hierarchy of CD4 T Cell Epitopes of the ANRS Lipo5 Synthetic Vaccine Relies on the Frequencies of Pre-Existing Peptide-Specific T Cells in Healthy Donors (2013) (17)
- Overexpression of GILZ in macrophages limits systemic inflammation while increasing bacterial clearance in sepsis in mice (2019) (17)
- Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques (2021) (17)
- The value of open-source clinical science in pandemic response: lessons from ISARIC (2021) (17)
- Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses (2017) (17)
- Delivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In Vivo (2015) (16)
- TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice (2020) (16)
- NK cell immune responses differ after prime and boost vaccination (2019) (16)
- Early Antiretroviral Therapy Preserves Functional Follicular Helper T and HIV-Specific B Cells in the Gut Mucosa of HIV-1–Infected Individuals (2018) (16)
- Therapeutic monitoring is necessary for the association itraconazole and efavirenz in a patient with AIDS and disseminated histoplasmosis. (2008) (15)
- Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys (2022) (15)
- Myocardial Gene Expression Profiling to Predict and Identify Cardiac Allograft Acute Cellular Rejection: The GET-Study (2016) (14)
- Presence of HIV-Specific CD4+ T-Cell Responses in HIV-Infected Subjects With Sustained Virologic Control After Highly Active Antiretroviral Therapy (2004) (14)
- Long-term CD4(+) and CD8(+) T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16). (2013) (13)
- Innate and secondary humoral responses are improved by increasing the time between MVA vaccine immunizations (2020) (13)
- Differential effects of low and high concentrations of interleukin 6 on human B cells (1990) (13)
- A new endpoint definition improved clinical relevance and statistical power in a vaccine trial. (2009) (13)
- A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus‐coinfected patients (2016) (13)
- Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals (2019) (13)
- Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV. (2012) (13)
- Subset- and Antigen-Specific Effects of Treg on CD8+ T Cell Responses in Chronic HIV Infection (2016) (13)
- Modulation of spontaneous B-cell differentiation in macroglobulinemia by retinoic acid. (1994) (13)
- High dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma. (1991) (13)
- Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design (2014) (13)
- HIV-1 prophylactic vaccines: state of the art (2016) (12)
- Inflammatory oedema of the legs: a new side-effect of lopinavir. (2001) (12)
- Therapeutic HIV vaccines: An update (2005) (11)
- Initiation of c-ART in HIV-1 Infected Patients Is Associated With a Decrease of the Metabolic Activity of the Thymus Evaluated Using FDG-PET/Computed Tomography (2012) (11)
- Altered Thymic Function during Interferon Therapy in HCV-Infected Patients (2012) (11)
- Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen (2018) (11)
- Modeling CD4+ T cells dynamics in HIV-infected patients receiving repeated cycles of exogenous Interleukin 7 (2016) (11)
- NK cells are primed by ANRS MVAHIV‐infected DCs, via a mechanism involving NKG2D and membrane‐bound IL‐15, to control HIV‐1 infection in CD4+ T cells (2014) (10)
- HIV specific responses induced in nonhuman primates with ANRS HIV-Lipo-5 vaccine combined with rMVA-HIV prime or boost immunizations. (2015) (10)
- Recent developments in clinical trial designs for HIV vaccine research (2015) (10)
- Cytokine-based modulation of immune function in HIV infection (2006) (10)
- Interleukine-2 Therapy Does Not Increase the Risk of Hodgkin or Non-Hodgkin Lymphoma in HIV-Infected Patients: Results From FHDH ANRS CO4 (2009) (10)
- Fc&ggr;RIIIa (CD16) Induction on Human T Lymphocytes and CD16pos T-Lymphocyte Amplification (2011) (10)
- Negative modulation of suppressive HIV-specific regulatory T cells by IL-2 adjuvanted therapeutic vaccine (2017) (10)
- Huge cutaneous plasmacytomas complicating multiple myeloma (1994) (10)
- Modified Vaccinia Virus Ankara Vector Induces Specific Cellular and Humoral Responses in the Female Reproductive Tract, the Main HIV Portal of Entry (2017) (10)
- Phase I/II Randomized Trial of Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC-HIV (vCP1452) Prime/LIPO-5 Boost in Healthy, HIV-1-Uninfected Adult Participants (2014) (9)
- HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates (2018) (9)
- Drug assessment in the Ebola virus disease epidemic in west Africa. (2015) (9)
- HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort) (2019) (9)
- Molecular and Cellular Dynamics in the Skin, the Lymph Nodes, and the Blood of the Immune Response to Intradermal Injection of Modified Vaccinia Ankara Vaccine (2018) (9)
- Optimization and evaluation of Luminex performance with supernatants of antigen-stimulated peripheral blood mononuclear cells (2016) (9)
- Immune alterations during SARS-CoV-2-related acute respiratory distress syndrome (2020) (8)
- Mechanisms of HIV-1 evasion to the antiviral activity of chemokine CXCL12 indicate potential links with pathogenesis (2021) (8)
- IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy--results from the ANRS CO4 cohort. (2010) (8)
- IL‐7 sensitizes human pre‐B cells but not pro‐B cells to Fas/APO‐1 (CD95)‐mediated apoptosis (1997) (8)
- Natural killer cell responses to dendritic cells infected by the ANRS HIV-1 vaccine candidate, MVAHIV. (2014) (8)
- Treatment of multiple myeloma by high dose chemotherapy, total body irradiation and autologous blood stem cell autograft. (1989) (8)
- Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients (2009) (8)
- Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial (2020) (7)
- [Cytokine therapies in HIV infection]. (2006) (7)
- Understanding the long-term evolution and predictors of sequelae of Ebola virus disease survivors in Guinea: A 48-month prospective, longitudinal cohort study (PostEboGui). (2021) (7)
- Early blood transcriptomic signature predicts patients' outcome after out-of-hospital cardiac arrest. (2019) (7)
- No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults (2016) (7)
- HIV‐1 induces apoptosis in cultured human neurons and microglial cells but not in astrocytes (1997) (7)
- Regulatory T cells differentially modulate the maturation and apoptosis of human CD 8 T-cell subsets * (2009) (7)
- [Neuronal apoptosis in the course of human immunodeficiency virus infection]. (1996) (7)
- IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques (2012) (7)
- Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection (2020) (6)
- Human challenge trial workshop: Focus on quality requirements for challenge agents, Langen, Germany, October 22, 2019. (2020) (6)
- Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy. (2008) (6)
- Combined Plasma Elevation of CRP, Intestinal-Type Fatty Acid-Binding Protein (I-FABP), and sCD14 Identify Older Patients at High Risk for Health Care-Associated Infections (2018) (6)
- SARS-CoV-2 Omicron potently neutralized by a novel antibody with unique Spike binding properties (2022) (6)
- Development of an epitope-based HIV-1 vaccine strategy from HIV-1 lipopeptide to dendritic-based vaccines (2017) (6)
- Multi-arm, multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventions. (2019) (6)
- Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses (2019) (6)
- Lymphoma and Epstein−Barr virus DNA in blood during interleukin‐2 therapy in antiretroviral‐naïve HIV‐1‐infected patients: a substudy of the ANRS 119 trial (2014) (6)
- Painful neck stiffness secondary to an intramedullary abscess of the spinal cord in a HIV infected patient: a case report (2002) (6)
- Acute interstitial nephritis with predominant plasmacytic infiltration in patients with HIV-1 infection. (2012) (6)
- Anti-CD40 Antibodies Fused to CD40 Ligand Have Superagonist Properties (2021) (6)
- Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (2020) (6)
- Innate and secondary humoral responses are improved by increasing the time between MVA vaccine immunizations (2020) (6)
- Impaired humoral and cellular immune responses to influenza vaccination in chronic obstructive pulmonary disease patients. (2017) (6)
- Single-cell analysis reveals divergent responses of human dendritic cells to the MVA vaccine (2021) (5)
- Durable natural killer cell responses after heterologous two-dose Ebola vaccination (2021) (5)
- Cellular CD 4 T Cell Responses to the Diphtheria-Derived Carrier Protein of Conjugated Pneumococcal Vaccine and Antibody Response to Pneumococcal Vaccination in HIV-Infected Adults (2010) (5)
- Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine (2021) (5)
- Temporal evolution of the humoral antibody response after Ebola virus disease in Guinea: a 60-month observational prospective cohort study. (2021) (5)
- CD4 regulation in human lymphoid non-T-cells: a role for the silencer element. (2007) (4)
- IL6 and lymphoproliferative disorders. (1991) (4)
- Proliferative memory SAMHD1low CD4+ T cells harbour high levels of HIV-1 with compartmentalized viral populations (2019) (4)
- Effects of Interferon-α and-γ on B Cell Differentiation in Macroglobulinemia (1996) (4)
- S100A9 Tetramers, Which are Ligands of CD85j, Increase the Ability of MVAHIV-Primed NK Cells to Control HIV Infection (2015) (4)
- Targeting human langerin promotes HIV-1 specific humoral immune responses (2021) (4)
- Response to a Letter to the Editor by Joachim Denner on HIV infection en route to endogenization: two cases. (2015) (4)
- Perspectives on interleukin-7 therapy in HIV infection (2007) (4)
- Analyzing cellular immunogenicity in vaccine clinical trials: a new statistical method including non-specific responses for accurate estimation of vaccine effect. (2019) (3)
- Unite forces to validate biomarkers in the quest for lasting HIV remission. (2016) (3)
- Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (2023) (3)
- Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults (2022) (3)
- Randomized Trial of Vaccines for Zaire Ebola Virus Disease. (2022) (3)
- NOTCH assembles a transcriptional repressive complex containing NuRD and PRC1 to repress genes involved in cell proliferation and differentiation (2019) (3)
- CD177, a specific marker of neutrophil activation, is a hallmark of COVID-19 severity and death (2020) (3)
- Perpetuation of vaccine memory T cell responses against SIV/HIV (2011) (3)
- Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines (2022) (3)
- T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial (2022) (3)
- A new method for integrated analysis applied to gene expression and cytokines secretion in response to LIPO-5 vaccine in HIV-negative volunteers (2012) (3)
- TLR9- and CD40-Targeting Vaccination Promotes Human B Cell Maturation and IgG Induction via pDC-Dependent Mechanisms in Humanized Mice (2021) (3)
- Immunothérapie de l'infection par le VIH (1999) (2)
- Role of regulatory T cells in the pathogenesis of HIV-1 infection (2009) (2)
- Late cerebral relapse of a Mycobacterium avium complex disseminated infection in an HIV-infected patient after cessation of antiretroviral therapy. (2003) (2)
- The Potential of Immune Modulation in Therapeutic HIV-1 Vaccination (2020) (2)
- A highly relevant and efficient single step method for simultaneous depletion and isolation of human regulatory T cells in a clinical setting. (2014) (2)
- Serum ST2 level is an independent predictor of all-cause mortality in HIV-infected patients. Aquitaine Cohort, France. (2017) (2)
- P19-45. Development of a therapeutic HIV vaccine comprised of autologous dendritic cells loaded with a mixture of lipopeptide HIV antigens (2009) (2)
- HGF and CXCL13, Two Antagonizing Cytokines in Lung Inflammation and Fibrosis, Predict the Severity and the Mortality of COVID-19 (2021) (2)
- HIV infection: what should be considered in approaches for a cure? (2012) (2)
- A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial (2021) (2)
- Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals (2018) (2)
- OA02-06 LB. Recombinant modified Vaccinia virus ankara expressing HIV-1 genes activates NK subset capable of controlling HIN infection in vitro (2009) (2)
- Effects of interferon-alpha and -gamma on B cell differentiation in macroglobulinemia. (1996) (2)
- [Deficiency of HIV-specific T cell responses: are the Treg guilty?] (2017) (1)
- Refining the DC-targeting vaccination for preventing emerging infectious diseases (2022) (1)
- IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques (2012) (1)
- A Framework to Identify Antigen-Expanded T Cell Receptor Clusters Within Complex Repertoires (2021) (1)
- [CMV infection in a patient with HIV. Diagnosis, evolution, principles of treatment]. (2000) (1)
- Cities central to HIV response for people who use drugs. (2016) (1)
- Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial (2018) (1)
- Targeting HIV Gag p24 to DICR on dendritic cells induces T cell and potent and long-lasting antibody responses in non-human primates (2012) (1)
- OA031-02. Regulatory T cells inhibit CD8 T cell proliferation in HIV-1 infection through CD39/adenosine pathway (2009) (1)
- UvA-DARE ( Digital Academic Repository ) CD 39 / Adenosine Pathway Is Involved in AIDS Progression (2011) (1)
- HIV-1 Tat complexes reveal subunit composition of active P-TEFb and stable association with 7SKsnRNP (2010) (1)
- Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients. (2017) (1)
- Common Variable Immunodeficiency Process Characterizes a Subset of Patients Impaired Antibody Affinity Maturation (2000) (1)
- Protection of human immunodeficiency virus encephalitis by a switch from zidovudine to didanosine (1996) (1)
- Immunotherapy in HIV infection; current and future challenges (2010) (1)
- Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients (2022) (1)
- NEURONAL APOPTOSIS IN HIV INFECTION: 105 (1995) (1)
- Seminal Plasma Exposures Strengthen Vaccine Responses in the Female Reproductive Tract Mucosae (2019) (1)
- The Route of Vaccine Administration Determines Whether Blood Neutrophils Undergo Long-Term Phenotypic Modifications (2021) (1)
- S04-04 OA. HIV-specific responses induced by anti-CD40 targeting antibodies (2009) (1)
- Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection (2022) (1)
- CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death (2022) (1)
- Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study (2022) (1)
- Functional Ex Vivo Testing of Alveolar Monocytes in Patients with Pneumonia-Related ARDS (2021) (1)
- Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients (2022) (1)
- mulTI-cohorT GeneTIc assocIaTIon sTudy reVeals cXcr 6 as a new chemokIne recePTor InVolVed In aIds lonG-Term non-ProGressIon (2011) (1)
- Health crisis: What opportunities for clinical drug research? (2021) (1)
- Chronic use of renin‐angiotensin‐aldosterone system blockers and mortality in COVID‐19: A multicenter prospective cohort and literature review (2021) (1)
- Differences in HADS and SF-36 scores 1 year after critical illness in COVID-19 patients (2022) (1)
- CD73+ CD127high Long-Term Memory CD4 T Cells Are Highly Proliferative in Response to Recall Antigens and Are Early Targets in HIV-1 Infection (2021) (1)
- A framework to identify antigen-expanded T Cell Receptor (TCR) clusters within complex repertoires (2021) (1)
- P17-04. Targeting HIV peptides to human dendritic cells via CD40 elicits expansion of multi-epitope polyfunctional CD4+ and CD8+ T cells in HIV patients (2009) (1)
- PLACE DE L'INTERLEUKINE 2 DANS LE TRAITEMENT DE L'INFECTION PAR LE VIH (1999) (0)
- P16-49. Broad types of cytokines secreted by Gag-specific T cells from HIV infected patients on HAART (2009) (0)
- Vaccination with dendritic cells loaded with HIV-1 lipopeptides elicits broad T cell immunity and control of viral load in HIV infected patients (2012) (0)
- P18-11. DALIA: dendritic cell and lipopeptide-induced immunity against AIDS: a phase I trial (2009) (0)
- Have Superagonist Properties Anti-CD40 Antibodies Fused to CD40 Ligand (2021) (0)
- A Monocentric, Prospective, Observational Study On Vaso-Occlusive Crisis (VOC) in Adult Sickle-Cell Disease (SCD). (2012) (0)
- Somatic hypermutation of immunoglobulin genes (2000) (0)
- Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19 (2023) (0)
- High Dose Chemotherapy and Blood Stem Cell Autologous Graft in Multiple Myeloma (1991) (0)
- Abstract 14505: An Early Transcriptomic Signature Predicts Poor Outcome After Out-of-hospital Cardiac Arrest (2017) (0)
- INTENSIVE CHEMOTHERAPY and G-CSF for HIV-ASSOCIATED NON-HODGKIN'S LYMPHOMA(LNHIV-91 regimen): 103 (1997) (0)
- Regulatory T cells modulate differentially the maturation and apoptosis of human CD8-T cell subsets Running Title: Treg MODULATE CD8 SUBSETS THROUGH PD-1/PDL1 PATHWAY (2009) (0)
- P17-10. A new AuxoGTU-HIV B DNA vaccine induce very long lasting HIV specific T cells response which is efficiently boosted with HIV LAI lipopeptides (2009) (0)
- This information is current as Infection After Simian Immunodeficiency Virus Producing Cells Early − Emergence of IL-17 AIDS Progression Is Associated with the Elbim and Jérôme (2009) (0)
- Purpura thrombopénique immunologique et déficit immunitaire commun variable: analyse de 22 cas (2001) (0)
- [Specific immunotherapy for HIV infection: objectives and limits]. (2005) (0)
- Antibodies to human CD39 and their use in inhibiting the activity of T-regulatory cells (2009) (0)
- P16-29. HIV Nef-specific T cells: Th1/CTL, Th2 and Th17 responses (2009) (0)
- [Biology of interleukin-6. Role in lymphoplasmacytic hemopathies]. (1992) (0)
- Cell therapy (SY5-1) Chairpersons: Masaru Taniguchi, Jacques Banchereau (2010) (0)
- A novel therapeutic vaccination delays cART-resistant HIV-1 reservoir rebound in HIV-1 infected humanized mice (2016) (0)
- T.85. Development of Prototype Vaccines that Target HIV Antigens to Human Dendritic Cells (2009) (0)
- Reply to Bordoni et al. (2016) (0)
- Immunological efficacy of pneumococcal vaccination including the 13-valent pneumococcal vaccine in adult patients with sickle-cell disease: results of the randomized DREVAC controlled trial. (2023) (0)
- Title : Modelling the response to vaccine in Non-Human Primates to define 1 SARS-CoV-2 mechanistic correlates of protection (0)
- NK Cell Subset Redistribution and Antibody Dependent Activation after Ebola Vaccination in Africans (2022) (0)
- Déficit immunitaire commun variable (1999) (0)
- Complement-dependent mpox virus-neutralizing antibodies in infected and vaccinated individuals (2023) (0)
- Human CD39 antibodies and their use to inhibit the activity of regulatory T cells (2009) (0)
- Immunization schedules used in this study. (2015) (0)
- Durable natural killer cell responses after heterologous two-dose Ebola vaccination (2021) (0)
- [Interest of Toxoplasma PCR for the early diagnosis of disseminated toxoplasmosis in an HIV-infected patient]. (2005) (0)
- [Interleukin 6 and lymphoplasmocytic proliferation]. (1993) (0)
- A NEW ENDPOINT DEFINITION IMPROVING CLINICAL RELEVA NCE AND STATISTICAL POWER IN VACCINE TRIALS (2008) (0)
- Profound Defect of Amphiregulin Secretion by Regulatory T Cells in the Gut of HIV-Treated Patients (2022) (0)
- ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19 (2022) (0)
- [IL 6 and lymphoproliferative diseases]. (1991) (0)
- REMONTEE DES LYMPHOCYTES AU COURS DU TRAITEMENT DU SIDA : REDISTRIBUTION OU PROLIFERATION ? (1998) (0)
- A Phase I/II Trial of Preventive HIV Vaccination with DNA and Poxviral-Vector in Healthy Subjects EV03/ANRS VAC20: Cytokine Production by T Cells (2013) (0)
- Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19 (2023) (0)
- through the CD39/ATP Axis Memory T Regulatory Cell Functions IL-7 Modulates In Vitro and In Vivo Human (2013) (0)
- Conservative treatment of primary gastric B-cell lymphoma of MALT-type arising in the setting of HIV infection and posttransplantation (2001) (0)
- Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response (2018) (0)
- Letter to the Editor (1997) (0)
- Brief Common variable immunodeficiency is associated with defective functions of dendritic cells (2004) (0)
- Toll-like receptor ligands differentially activate human innate immune system and distinctively enhance antigen-specific T cell response to vaccination in humanized mice (VAC4P.1105) (2015) (0)
- PatientsSubsets That Are Depleted in HIV-Infected Human CD90 Identifies Th17/Tc17 T Cell (2011) (0)
- In vitro identification of human pro-B cells that give rise to macrophages, natural killer cells, and T cells (2003) (0)
- L’immunothérapie de l’infection par le VIH (2002) (0)
- 580 Spontaneous replication stress in Hair Follicle Stem Cells leads to inflammation in Hidradenitis Suppurativa (2019) (0)
- The evaluation of immune-based approaches to achieve an antiretroviral therapy (ART)-free remission of HIV infection requires demonstration of efficacy through ART interruption placebo-controlled trials (2019) (0)
- IL-7 abrogates memory T regulatory cell functions by modulation of CD39/ATP axis in vitro and in vivo in HIV infected and non-infected patients (2012) (0)
- 122 Interplay Between HIV Replication and MicroRNAs (2011) (0)
- SARS-CoV-2 mechanistic correlates of protection: insight from modelling response to vaccines (2021) (0)
- P19-19. MVA vaccines are efficiently cross-presented by DCs and do not enhance HIV replication in DC/T cell cultures (2009) (0)
- A new 3 p 25 locus is associated with liver fibrosis progression in HIV / HCV co-infected patients (2016) (0)
- Impact of smoking and lung alterations on aging related manifestations in HIV patients (2017) (0)
- Vaccination thérapeutique de l'infection par le VIH (2002) (0)
- Author response for "Accelerated thymopoiesis and improved T cell responses in HLA‐A2/‐DR2 transgenic BRGS‐based human immune system mice" (2019) (0)
- Memory CD4+CD45RO+SAMHD1low Cells Exhibit Distinct Genes Profile and Contain the Highest Level of HIV-1 DNA With Segregated HIV-1 Populations (2018) (0)
- Dendritic cell targeting anti-CD40 antibody-CD40L-HIV-1 vaccines are adjuvant intrinsic (2020) (0)
- L’éradication du VIH en question (1997) (0)
- Anti-SARS-CoV-2 cellular response after 2 and 3 doses of BNT162b2 mRNA vaccine in lymphoma patients receiving anti-CD20 antibodies (2023) (0)
- N-01 Vascularites crbrales primitives isoles chez des patients infects par le VIH-1 (2008) (0)
- Optimization and evaluation of Luminex performance with supernatants of antigen-stimulated peripheral blood mononuclear cells (2016) (0)
- This information is current as Antiviral Immune Responses Instructs Skin Langerhans Cells To Prime α Macrophage-and Neutrophil-Derived TNF - (2014) (0)
- Immunization with αDCIR.Gagp24 without adjuvant generates high titers of HIV Gagp24 antibody responses in NHPs. (2015) (0)
This paper list is powered by the following services:
Other Resources About Yves Lévy
What Schools Are Affiliated With Yves Lévy?
Yves Lévy is affiliated with the following schools:
